首页> Clinical and experimental rheumatology> Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre

Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre

导出原文传递

翻译打印收藏纠错

第一作者： Cacciapaglia, F.

作者： Cacciapaglia, F. ^[1] ; Renna, D. ; Fornaro, M. ; Venerito, V. ; Lopalco, G. ; Iannone, F.

作者单位： Dept Emergence Med & Transplantat DETO,Univ Bari Aldo Moro ^[1]

发布时间 2022-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and experimental rheumatology

2021年39卷5期

1147-1148页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical and experimental rheumatology

2021年39卷5期

1147-1148页

检索历史清除

Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre

Clinical and experimental rheumatology

相似文献

同项目论文

Clinical and experimental rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre

Clinical and experimental rheumatology

相似文献

同项目论文

Clinical and experimental rheumatology

相关期刊

检索历史清除